NSD2 and Miyoshi myopathy: Chromothripsis is associated with known high-risk genetic alterations in MM, including IGH translocations involving MMSET, MAF, or MAFB; biallelic inactivation of TP53, deletion of 1p12, and high APOBEC mutational burden [619].